La Jolla, CA, United States of America

Robert Davis

This inventor holds 1 USPTO granted patent. Top assignee: Ludwig Institute for Cancer Research Limited. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Davis. Retrieved from https://idiyas.com/inventor/robert-davis-z3isgh1c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Robert Davis

Introduction

Robert Davis is an accomplished inventor based in La Jolla, California. He has made significant contributions to the field of cancer research, particularly through his innovative approaches to treatment.

Latest Patents

Robert Davis holds a patent for "Methods of treating cancer with PLK4 inhibitors." This patent outlines compounds and methods for inhibiting PLK4 and for treating cancer in subjects in need thereof. His work in this area is crucial for advancing cancer therapies.

Career Highlights

Davis is affiliated with the Ludwig Institute for Cancer Research Limited, where he focuses on developing new cancer treatment methodologies. His dedication to research and innovation has positioned him as a key figure in the fight against cancer.

Collaborations

He has collaborated with notable researchers such as Karen Oegema and Andrew Shiau, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Robert Davis's work exemplifies the impact of innovative research in cancer treatment. His contributions are paving the way for new therapeutic options that could benefit many patients in need.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…